Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone

Y Zheng, J Yang, J Qian, L Zhang, Y Lu, H Li… - Journal of molecular …, 2012 - Springer
NVP-BKM120 is a novel phosphatidylinositol 3-kinase (PI3K) inhibitor and is currently being
investigated in phase I clinical trials in solid tumors. This study aimed to evaluate the …
被引用次数：71 相关文章

[引用][C] Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with …

Y ZHENG, J YANG, S HONG… - Journal of …, 2012 - pascal-francis.inist.fr
Author YUHUAN ZHENG 1; JING YANG 1; SUNGYOUL HONG 1; SHEEBA THOMAS 1;
SHAH, Jatin 1; BALADANDAYUTHAPANI, Veera 2; KWAK, Larry W 1; QING YI 1; JIANFEI …

Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone

Y Zheng, J Yang, J Qian, L Zhang, Y Lu, H Li… - Journal of Molecular …, 2012 - infona.pl
NVP-BKM120 is a novel phosphatidylinositol 3-kinase (PI3K) inhibitor and is currently being
investigated in phase I clinical trials in solid tumors. This study aimed to evaluate the …
[HTML] nih.gov

[HTML][HTML] Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with …

Y Zheng, J Yang, J Qian, L Zhang, Y Lu… - Journal of molecular …, 2012 - ncbi.nlm.nih.gov
NVP-BKM120 is a novel phosphatidylinositol 3-kinase (PI3K) inhibitor and is currently being
investigated in phase I clinical trials in solid tumors. This study aimed to evaluate the …

Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone

Y Zheng, J Yang, J Qian… - Journal of …, 2012 - mdanderson.elsevierpure.com
NVP-BKM120 is a novel phosphatidylinositol 3-kinase (PI3K) inhibitor and is currently being
investigated in phase I clinical trials in solid tumors. This study aimed to evaluate the …

[引用][C] Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with …

Y Zheng, J Yang, J Qian, L Zhang, Y Lu, H Li… - Journal of Molecular …, 2011 - cir.nii.ac.jp
Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma
cells and shows synergistic anti-myeloma activity with dexamethasone | CiNii Research CiNii …

Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone

Y Zheng, J Yang, J Qian, L Zhang… - Journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
NVP-BKM120 is a novel phosphatidylinositol 3-kinase (PI3K) inhibitor and is currently being
investigated in phase I clinical trials in solid tumors. This study aimed to evaluate the …

Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone.

Y Zheng, J Yang, J Qian, L Zhang… - Journal of …, 2012 - search.ebscohost.com
NVP-BKM120 is a novel phosphatidylinositol 3-kinase (PI3K) inhibitor and is currently being
investigated in phase I clinical trials in solid tumors. This study aimed to evaluate the …

Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone.

Y Zheng, J Yang, J Qian, L Zhang, Y Lu… - Journal of Molecular …, 2011 - europepmc.org
NVP-BKM120 is a novel phosphatidylinositol 3-kinase (PI3K) inhibitor and is currently being
investigated in phase I clinical trials in solid tumors. This study aimed to evaluate the …

[引用][C] Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with …

Y Zheng, J Yang, J Qian, L Zhang, Y Lu, H Li… - Journal of Molecular …, 2012 - Springer